-
1
-
-
1642482564
-
-
Centers for Disease Control and Prevention. Atlanta CDC, Available at/(accessed 13 September 2014
-
Centers for Disease Control and Prevention. Lyme Disease. Atlanta: CDC, 2014. Available at: http://www.cdc.gov/lyme/(accessed 13 September 2014).
-
(2014)
Lyme Disease
-
-
-
2
-
-
84855900042
-
Of ticks, mice and men: Understanding the dual-host lifestyle of lyme disease spirochaetes
-
Radolf JD, Caimano MJ, Stevenson B, Hu LT. Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 2012; 10: 87-99.
-
(2012)
Nat Rev Microbiol
, vol.10
, pp. 87-99
-
-
Radolf, J.D.1
Caimano, M.J.2
Stevenson, B.3
Hu, L.T.4
-
3
-
-
84903752210
-
-
Centers for Disease Control and Prevention. Atlanta CDC, Available at (accessed 13 September 2014
-
Centers for Disease Control and Prevention. Post-treatment Lyme Disease Syndrome. Atlanta: CDC, 2014. Available at: http://www.cdc.gov/lyme/postLDS/index.html (accessed 13 September 2014).
-
(2014)
Post-treatment Lyme Disease Syndrome
-
-
-
4
-
-
75749107000
-
Ineffectiveness of tigecycline against persistent borrelia burgdorferi
-
Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother 2010; 54: 643-651.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 643-651
-
-
Barthold, S.W.1
Hodzic, E.2
Imai, D.M.3
Feng, S.4
Yang, X.5
Luft, B.J.6
-
5
-
-
84855694512
-
Persistence of borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection
-
Embers ME, Barthold SW, Borda JT et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One 2012; 7: e29914.
-
(2012)
PLoS One
, vol.7
, pp. e29914
-
-
Embers, M.E.1
Barthold, S.W.2
Borda, J.T.3
-
6
-
-
84899865015
-
Resurgence of persisting non-cultivable borrelia burgdorferi following antibiotic treatment in mice
-
Hodzic E, Imai D, Feng S, Barthold SW. Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice. PLoS One 2014; 9: e86907.
-
(2014)
PLoS One
, vol.9
, pp. e86907
-
-
Hodzic, E.1
Imai, D.2
Feng, S.3
Barthold, S.W.4
-
7
-
-
0031060071
-
Persistence of borrelia burgdorferi in experimentally infected dogs after antibiotic treatment
-
Straubinger RK, Summers BA, Chang YF, Appel MJ. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 1997; 35: 111-116.
-
(1997)
J Clin Microbiol
, vol.35
, pp. 111-116
-
-
Straubinger, R.K.1
Summers, B.A.2
Chang, Y.F.3
Appel, M.J.4
-
8
-
-
73249127383
-
Destruction of spirochete borrelia burgdorferi round-body propagules (rbs) by the antibiotic tigecycline
-
Brorson O, Brorson SH, Scythes J, MacAllister J, Wier A, Margulis L. Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci USA 2009; 106: 18656-18661.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 18656-18661
-
-
Brorson, O.1
Brorson, S.H.2
Scythes, J.3
MacAllister, J.4
Wier, A.5
Margulis, L.6
-
9
-
-
84868108265
-
Characterization of biofilm formation by borrelia burgdorferi in vitro
-
Sapi E, Bastian SL, Mpoy CM et al. Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One 2012; 7: e48277.
-
(2012)
PLoS One
, vol.7
, pp. e48277
-
-
Sapi, E.1
Bastian, S.L.2
Mpoy, C.M.3
-
10
-
-
0037634212
-
Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression
-
Diterich I, Rauter C, Kirschning CJ, Hartung T. Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun 2003; 71: 3979-3987.
-
(2003)
Infect Immun
, vol.71
, pp. 3979-3987
-
-
Diterich, I.1
Rauter, C.2
Kirschning, C.J.3
Hartung, T.4
-
11
-
-
84859698233
-
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of borrelia burgdorferi
-
Sapi E, Kaur N, Anyanwu S et al. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist 2011; 4: 97-113.
-
(2011)
Infect Drug Resist
, vol.4
, pp. 97-113
-
-
Sapi, E.1
Kaur, N.2
Anyanwu, S.3
-
12
-
-
84903757348
-
Identification of novel activity against borrelia burgdorferi persisters using an fda approved drug library
-
Feng J, Wang T, Shi W et al. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microb Infect 2014; 3: e49.
-
(2014)
Emerg Microb Infect
, vol.3
, pp. e49
-
-
Feng, J.1
Wang, T.2
Shi, W.3
-
13
-
-
84909606249
-
An optimized sybr green i/pi assay for rapid viability assessment and antibiotic susceptibility testing for borrelia burgdorferi
-
Feng J, Wang T, Zhang S, Shi W, Zhang Y. An optimized SYBR Green I/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi. PLoS One 2014; 9: e111809.
-
(2014)
PLoS One
, vol.9
, pp. e111809
-
-
Feng, J.1
Wang, T.2
Zhang, S.3
Shi, W.4
Zhang, Y.5
-
14
-
-
84926341095
-
Drug combinations against borrelia burgdorferi persisters in vitro: Eradication achieved by using daptomycin, cefoperazone and doxycycline
-
Feng J, Auwaerter PG, Zhang Y. Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS One 2015; 10: e0117207.
-
(2015)
PLoS One
, vol.10
, pp. e0117207
-
-
Feng, J.1
Auwaerter, P.G.2
Zhang, Y.3
-
15
-
-
84989308889
-
-
Developmental Therapeutics Program NCI/NIH. Shady Grove: DTP, Available at accessed 15 March 2015)
-
Developmental Therapeutics Program NCI/NIH. Open Repository Collection of Synthetics and Pure Natural Products. Shady Grove: DTP, 2014. Available at: http://dtp.nci.nih.gov/branches/dscb/repo-open.html (accessed 15 March 2015).
-
(2014)
Open Repository Collection of Synthetics and Pure Natural Products
-
-
-
16
-
-
0034622803
-
Improvements in image analysis and fluorescence microscopy to discriminate and enumerate bacteria and viruses in aquatic samples
-
Shopov A, Williams SC, Verity PG. Improvements in image analysis and fluorescence microscopy to discriminate and enumerate bacteria and viruses in aquatic samples. Aquat Microb Ecol 2000; 22:103-110.
-
(2000)
Aquat Microb Ecol
, vol.22
, pp. 103-110
-
-
Shopov, A.1
Williams, S.C.2
Verity, P.G.3
-
17
-
-
84962101907
-
-
Clinical and Laboratory Standards Institute. CLSI document M100-S17 Wayne: CLSI, 2007. Available at (accessed 11 January 2015)
-
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. CLSI document M100-S17 2007; 27: 154-161. Wayne: CLSI, 2007. Available at: http://www.microbilab-bg.com/CLSI.pdf (accessed 11 January 2015).
-
(2007)
Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement
, vol.27
, pp. 154-161
-
-
-
18
-
-
0018088719
-
Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents
-
Moody MR, Morris MJ, Young VM, Moye LA 3rd, Schimpff SC, Wiernik PH. Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents. Antimicrob Agents Chemother 1978; 14: 737-742.
-
(1978)
Antimicrob Agents Chemother
, vol.14
, pp. 737-742
-
-
Moody, M.R.1
Morris, M.J.2
Young, V.M.3
Moye, L.A.4
Schimpff, S.C.5
Wiernik, P.H.6
-
19
-
-
84989316828
-
-
Developmental Therapeutics Program NCI/NIH. Shady Grove: DTP, Available at accessed 11 January 2015)
-
Developmental Therapeutics Program NCI/NIH. Mechanistic Set Information. Shady Grove: DTP, 2015. Available at: http://dtp.nci.nih.gov/branches/dscb/mechanistic-explanation.html (accessed 11 January 2015).
-
(2015)
Mechanistic Set Information
-
-
-
20
-
-
84989347700
-
-
Developmental Therapeutics Program NCI/NIH. Shady Grove: DTP, Available at accessed 11 January 2015)
-
Developmental Therapeutics Program NCI/NIH. Natural Products Set III. Shady Grove: DTP, 2015. Available at: http://dtp.nci.nih.gov/branches/dscb/natprod-explanation2.html (accessed 11 January 2015).
-
(2015)
Natural Products Set III
-
-
-
21
-
-
0026658194
-
In vitro antimicrobial susceptibility testing of borrelia burgdorferi: A microdilution mic method and time-kill studies
-
Dever LL, Jorgensen JH, Barbour AG. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol 1992; 30: 2692-2697.
-
(1992)
J Clin Microbiol
, vol.30
, pp. 2692-2697
-
-
Dever, L.L.1
Jorgensen, J.H.2
Barbour, A.G.3
-
22
-
-
0029395339
-
In vitro antimicrobial susceptibility testing of borrelia burgdorferi: Influence of test conditions on minimal inhibitory concentration (mic) values
-
Boerner J, Failing K, Wittenbrink MM. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values. Zentralbl Bakteriol 1995; 283: 49-60.
-
(1995)
Zentralbl Bakteriol
, vol.283
, pp. 49-60
-
-
Boerner, J.1
Failing, K.2
Wittenbrink, M.M.3
-
23
-
-
0014066067
-
Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease clinical evaluation with special reference to childhood leukemia
-
Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 1967; 20: 333-353.
-
(1967)
Cancer
, vol.20
, pp. 333-353
-
-
Tan, C.1
Tasaka, H.2
Yu, K.P.3
Murphy, M.L.4
Karnofsky, D.A.5
-
24
-
-
27544456829
-
Syntheses and biological activities of daunorubicin analogs with uncommon sugars
-
Zhu L, Cao X, Chen W, Zhang G, Sun D, Wang PG. Syntheses and biological activities of daunorubicin analogs with uncommon sugars. Bioorg Med Chem 2005; 13: 6381-6387.
-
(2005)
Bioorg Med Chem
, vol.13
, pp. 6381-6387
-
-
Zhu, L.1
Cao, X.2
Chen, W.3
Zhang, G.4
Sun, D.5
Wang, P.G.6
-
25
-
-
0016798341
-
Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis
-
Mizuno NS, Zakis B, Decker RW. Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis. Cancer Res 1975; 35: 1542-1546.
-
(1975)
Cancer Res
, vol.35
, pp. 1542-1546
-
-
Mizuno, N.S.1
Zakis, B.2
Decker, R.W.3
-
26
-
-
0027194055
-
Different modes of anthracycline interaction with topoisomerase II separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance
-
Jensen PB, Sorensen BS, Sehested M et al. Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance. Biochem Pharmacol 1993; 45: 2025-2035.
-
(1993)
Biochem Pharmacol
, vol.45
, pp. 2025-2035
-
-
Jensen, P.B.1
Sorensen, B.S.2
Sehested, M.3
-
27
-
-
77954187741
-
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
-
Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010; 17: 421-433.
-
(2010)
Chem Biol
, vol.17
, pp. 421-433
-
-
Pommier, Y.1
Leo, E.2
Zhang, H.3
Marchand, C.4
-
28
-
-
0020363268
-
The mode of action of nanaomycins d and a on a gram-negative marine bacterium vibrio alginolyticus
-
Hayashi M, Unemoto T,Minami-Kakinuma S, Tanaka H, Omura S. The mode of action of nanaomycins D and A on a gram-negative marine bacterium Vibrio alginolyticus. J Antibiot 1982; 35: 1078-1085.
-
(1982)
J Antibiot
, vol.35
, pp. 1078-1085
-
-
Hayashi, M.1
Unemoto Tminami-Kakinuma, S.2
Tanaka, H.3
Omura, S.4
-
29
-
-
84903291479
-
Bis-naphtho-gamma-pyrones from fungi and their bioactivities
-
Lu S, Tian J, Sun W et al. Bis-naphtho-gamma-pyrones from fungi and their bioactivities. Molecules 2014; 19: 7169-7188.
-
(2014)
Molecules
, vol.19
, pp. 7169-7188
-
-
Lu, S.1
Tian, J.2
Sun, W.3
-
30
-
-
0034780806
-
Bacterial fatty acid biosynthesis targets for antibacterial drug discovery
-
Campbell JW, Cronan JE Jr. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol 2001; 55: 305-332.
-
(2001)
Annu Rev Microbiol
, vol.55
, pp. 305-332
-
-
Campbell, J.W.1
Cronan, J.E.2
-
31
-
-
37649016653
-
Anticancer and immunosuppressive properties of bacterial prodiginines
-
Williamson NR, Fineran PC, Gristwood T, Chawrai SR, Leeper FJ, Salmond GP. Anticancer and immunosuppressive properties of bacterial prodiginines. Future Microbiol 2007; 2: 605-618.
-
(2007)
Future Microbiol
, vol.2
, pp. 605-618
-
-
Williamson, N.R.1
Fineran, P.C.2
Gristwood, T.3
Chawrai, S.R.4
Leeper, F.J.5
Salmond, G.P.6
-
32
-
-
0000134648
-
Crosslinking of DNA by enzymatically or chemically activated mitomycins and porfiromycins bifunctionally ''alkylating'' antibiotics
-
Szybalski W, Iyer VN. Crosslinking of DNA by enzymatically or chemically activated mitomycins and porfiromycins, bifunctionally ''alkylating'' antibiotics. Fed Proc 1964; 23: 946-957.
-
(1964)
Fed Proc
, vol.23
, pp. 946-957
-
-
Szybalski, W.1
Iyer, V.N.2
-
33
-
-
0029360580
-
Small, fast and deadly (but very selective
-
TomaszM.Mitomycin C: small, fast and deadly (but very selective). Chem Biol 1995; 2: 575-579.
-
(1995)
Chem Biol
, vol.2
, pp. 575-579
-
-
Tomasz, M.1
Mitomycin, C.2
-
34
-
-
0016315511
-
Actinomycin. Chemistry and mechanism of action
-
Hollstein U. Actinomycin. Chemistry and mechanism of action. Chem Rev 1974; 74: 625-652.
-
(1974)
Chem Rev
, vol.74
, pp. 625-652
-
-
Hollstein, U.1
-
35
-
-
0004820949
-
Actinomycin and DNA transcription
-
Sobell HM. Actinomycin and DNA transcription. Proc Natl Acad Sci USA 1985; 82: 5328-5331.
-
(1985)
Proc Natl Acad Sci USA
, vol.82
, pp. 5328-5331
-
-
Sobell, H.M.1
-
36
-
-
84892188759
-
Persisters, persistent infections and the yin-yang model
-
Zhang Y. Persisters, persistent infections and the Yin-Yang model. Emerg Microb Infect 2014; 3: e3.
-
(2014)
Emerg Microb Infect
, vol.3
, pp. e3
-
-
Zhang, Y.1
|